X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.clinicaltrialsarena.com/news/antabio-on-quest-to-tackle-antibiotic-resistance/
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-22-2023-51785.pdf
https://health.economictimes.indiatimes.com/news/pharma/anti-diabetes-drugs-and-patented-antivirals-to-get-cheaper-nlem-notified/95483953
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/diabetes-patented-tb-hiv-drugs-enter-essential-list/articleshow/94185393.cms
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210773
https://www.fiercepharma.com/pharma/merck-scores-zerbaxa-label-expansion-years-after-cubist-buyout
https://www.ema.europa.eu/documents/product-information/vabomere-epar-product-information_en.pdf
https://www.pharmacompass.com/pdf/news/Enforcement-Report-Week-of-October-31-2018-1540974685.pdf
http://www.pharmatimes.com/news/chmp_puts_13_therapies_forward_for_eu_approval_1253165
https://www.ema.europa.eu/documents/press-release/new-medicine-treat-infections-adults_en.pdf
https://www.raps.org/news-and-articles/news-articles/2018/9/chmp-backs-13-new-medicines-maintains-negative-op?utm_source=MagnetMail&utm_medium=Email%20&utm_campaign=RF%20Today%20%7C%2021%20September
https://globenewswire.com/news-release/2018/08/03/1547099/0/en/Melinta-Therapeutics-Announces-Vabomere-meropenem-and-vaborbactam-Granted-New-Technology-Add-On-Payment-by-CMS.html
https://www.pharmacompass.com/pdf/news/hospira-healthcare-india-pvt-ltd-on-fda-import-alert-list-1549480434.pdf
https://www.pharmacompass.com/pdf/news/gattex-teduglutide-amlodipine-and-valsartan-tabs-shire-nps-pharm-v-par-pharma-et-al-1533038693.pdf
https://investors.sperotherapeutics.com/news-releases/news-release-details/spero-therapeutics-appoints-david-melnick-md-chief-medical
https://www.prnewswire.com/news-releases/successful-usfda-inspection-of-asymchem-fuxin-1-carbapenem-manufacturing-facility-300658472.html
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/astrazeneca-gets-extension-for-meronem-withdrawal-till-august-31/articleshow/59804872.cms
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205835
http://www.businesswire.com/news/home/20170221005827/en/Medicines-Company-Announces-FDA-Filing-Acceptance-Drug/?feedref=JjAwJuNHiystnCoBq_hl-WFAllVCLJFCqzlmaJ8DKHU4plfPZtlGYRDUHCSmgbii6XkLWuQZD-HgGRnjQvCyg3iCfEFIaJW7-otp9V1XQiK2eHTJy3ZqOEt7kKgLu20J
http://www.drug-dev.com/Main/Current-News/Achaogen-Announces-Positive-Results-in-Phase-III-T-1786.aspx
http://247wallst.com/healthcare-business/2016/12/12/achaogen-rises-on-late-stage-win/
http://www.business-standard.com/article/markets/astrazeneca-pharma-falls-on-receiving-termination-notice-for-meronem-116082500159_1.html
https://www.pharmacompass.com/pdf/news/hospira-healthcare-india-private-limited-fails-edqm-inspection-1471672382.pdf
http://www.fiercebiotech.com/biotech/medicines-co-preps-for-fda-ema-submission-positive-top-line-pivotal-data-for-carbavance
https://www.pharmacompass.com/pdf/news/us-fda-enforcement-report-8june2016-1465388450.pdf
https://www.pharmacompass.com/pdf/news/amneal-pharms-generic-meropenem-approved-in-us-as-antibiotic-1460706607.pdf
http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-0351-2015&w=01282015&lang=eng
http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-0303-2015&w=12242014&lang=eng
Market Place
Share 
